Originalauszug anzeigen · cc by
Daptomycin is licensed in adults for the management of Staphylococcus aureus methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg/Kg/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.
Auszug in der Originalsprache. Polilli E, Ursini T, Mazzotta E, Sozio F, Savini V, D'Antonio D, Barbato M, Consorte A, Parruti G. · Lizenz: cc by. Für den vollständigen Kontext die Originalpublikation öffnen.
Herkunft und Zuordnung
FindZebra
Datensatz: fabry:22404900
Quellenstand: f262dbc3a1d234f500d9173f9ebf8d19996b03ba